Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gailani

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
Blood|June 4, 2021
The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trialChristina U Lorentz, Erik I Tucker, Norah G Verbout, et al.
Blood|January 11, 2014
Factor XII inhibition reduces thrombus formation in a primate thrombosis modelAnton Matafonov, Philberta Y Leung, Adam E Gailani, et al.
The Journal of Biological Chemistry|December 20, 2024
The physicochemical properties of lipopolysaccharide chemotypes regulate activation of the contact pathway of blood coagulationAndré L Lira, Berk Taskin, Cristina Puy, et al.
Blood Advances|February 28, 2019
Inhibition of contact-mediated activation of factor XI protects baboons against <i>S aureus</i>-induced organ damage and deathRobert Silasi, Ravi Shankar Keshari, Cristina Lupu, et al.
Blood Advances|January 15, 2020
Differential roles of factors IX and XI in murine placenta and hemostasis under conditions of low tissue factorSteven P Grover, Clare M Schmedes, Alyson C Auriemma, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 29, 2022
Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke PreventionMukul Sharma, Carlos A Molina, Kazunori Toyoda, et al.
Thrombosis Research|September 22, 2015
Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS)Arina J ten Cate-Hoek, Jeffrey I Weitz, David Gailani, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2025
Dysfunctional HDL Promotes Platelet Apoptosis and Thrombosis in Familial HypercholesterolemiaKarthik Dhanabalan, Honglei Li, Patricia G Yancey, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 26, 2018
Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In VivoJevgenia Zilberman-Rudenko, Stéphanie E Reitsma, Cristina Puy, et al.
Blood|February 18, 2021
Factor XII plays a pathogenic role in organ failure and death in baboons challenged with Staphylococcus aureusRobert Silasi, Ravi S Keshari, Girija Regmi, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Blood|June 4, 2021
The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trialChristina U Lorentz, Erik I Tucker, Norah G Verbout, et al.
Blood|January 11, 2014
Factor XII inhibition reduces thrombus formation in a primate thrombosis modelAnton Matafonov, Philberta Y Leung, Adam E Gailani, et al.
The Journal of Biological Chemistry|December 20, 2024
The physicochemical properties of lipopolysaccharide chemotypes regulate activation of the contact pathway of blood coagulationAndré L Lira, Berk Taskin, Cristina Puy, et al.
Blood Advances|February 28, 2019
Inhibition of contact-mediated activation of factor XI protects baboons against <i>S aureus</i>-induced organ damage and deathRobert Silasi, Ravi Shankar Keshari, Cristina Lupu, et al.
Blood Advances|January 15, 2020
Differential roles of factors IX and XI in murine placenta and hemostasis under conditions of low tissue factorSteven P Grover, Clare M Schmedes, Alyson C Auriemma, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 29, 2022
Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke PreventionMukul Sharma, Carlos A Molina, Kazunori Toyoda, et al.
Thrombosis Research|September 22, 2015
Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS)Arina J ten Cate-Hoek, Jeffrey I Weitz, David Gailani, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2025
Dysfunctional HDL Promotes Platelet Apoptosis and Thrombosis in Familial HypercholesterolemiaKarthik Dhanabalan, Honglei Li, Patricia G Yancey, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 26, 2018
Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In VivoJevgenia Zilberman-Rudenko, Stéphanie E Reitsma, Cristina Puy, et al.
Blood|February 18, 2021
Factor XII plays a pathogenic role in organ failure and death in baboons challenged with Staphylococcus aureusRobert Silasi, Ravi S Keshari, Girija Regmi, et al.
Pageof 17